Edition:
United States

People: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,531.40GBp
21 Sep 2018
Change (% chg)

45.60 (+3.07%)
Prev Close
1,485.80
Open
1,492.80
Day's High
1,531.40
Day's Low
1,492.60
Volume
15,124,800
Avg. Vol
8,099,517
52-wk High
1,634.48
52-wk Low
1,235.20

Walmsley, Emma 

Ms. Emma Walmsley is Chief Executive Officer, Executive Director of GlaxoSmithKline PLC. Emma joined GSK in 2010 with responsibility for Consumer Healthcare, Europe and was subsequently appointed President of GlaxoSmithKline Consumer Healthcare in October 2011. She has been a member of GSK’s Corporate Executive Team since 2011 and was appointed CEO of GSK Consumer Healthcare, a joint venture between GSK and Novartis, from its creation in March 2015 until her appointment as GSK CEO Designate in September 2016. Emma joined the GSK Board on 1 January 2017 and succeeded Sir Andrew Witty as GSK CEO on 1 April 2017. Prior to joining GSK, Emma worked with L’Oreal for 17 years where she held a variety of marketing and general management roles in Paris, London and New York. From 2007, she was based in Shanghai as General Manager, Consumer Products for L’Oreal China. Emma was a Non-Executive Director of Diageo plc from 1 January to 21 September 2016. She holds an MA in Classics and Modern Languages from Oxford University.

Basic Compensation

Total Annual Compensation, GBP 2,505,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP 2,378,000
Fiscal Year Total, GBP 4,883,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --